Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for China Health Industries Holdings, Inc. (CHHE : OTC)
 
 • Company Description   
China Health Industries Holdings Inc. is a manufacturer of health food products through its subsidiaries Harbin Humankind Biology Technology Co., Limited and Heilongjiang Huimeijia Pharmaceutical Co., Ltd. The Company's operating segments consists of Humankind, HLJ Huimeijia and others. Humankind is engaged in the manufacturing and sale of health products. HLJ Huimeijia is involved in the manufacturing and distribution of tincture; ointments; rubber paste, including hormones; topical solution, suppositories, liniment, including traditional Chinese medicine extractions; enemas and oral liquids. China Health Industries Holdings Inc. is based in Harbin City, the Peoples Republic of China.

Number of Employees:

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.20 Daily Weekly Monthly
20 Day Moving Average: 0 shares
Shares Outstanding: 64.95 (millions)
Market Capitalization: $13.00 (millions)
Beta: -25.84
52 Week High: $0.65
52 Week Low: $0.20
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 0.00% -3.74%
12 Week 0.00% -15.89%
Year To Date -27.24% -31.86%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
3199-1 Longxiang Road Songbei District
-
Harbin,F4 150028
CHN
ph: 86-451-8810-0688
fax: -
ir@chinahealthindustries.com http://www.chinahealthindustries.com
 
 • General Corporate Information   
Officers
Xin Sun - Chief Executive Officer;Chief Financial Officer
- - -
- - -
- - -
- - -

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 169398104
SIC: 2834
Fiscal Year
Fiscal Year End: June
Last Reported Quarter: -
Next Expected EPS Date: -
Share - Related Items
Shares Outstanding: 64.95
Most Recent Split Date: (:1)
Beta: -25.84
Market Capitalization: $13.00 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: -  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: 47.17
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
06/30/25 - -
03/31/25 - -
12/31/24 - -
ROA
06/30/25 - -
03/31/25 - -
12/31/24 - -
Current Ratio
06/30/25 - -
03/31/25 - -
12/31/24 - -
Quick Ratio
06/30/25 - -
03/31/25 - -
12/31/24 - -
Operating Margin
06/30/25 - -
03/31/25 - -
12/31/24 - -
Net Margin
06/30/25 - -
03/31/25 - -
12/31/24 - -
Pre-Tax Margin
06/30/25 - -
03/31/25 - -
12/31/24 - -
Book Value
06/30/25 - -
03/31/25 - -
12/31/24 - -
Inventory Turnover
06/30/25 - -
03/31/25 - -
12/31/24 - -
Debt-to-Equity
06/30/25 - -
03/31/25 - -
12/31/24 - -
Debt-to-Capital
06/30/25 - -
03/31/25 - -
12/31/24 - -
 

Powered by Zacks Investment Research ©